C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/88 (2006.01) A61K 31/445 (2006.01) C07D 401/12 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01)
Patent
CA 2067759
Muscarinic receptor antagonists, particularly useful in the treatment of irritable bowel syndrome, of formula (I), or a acceptable salt thereof, where m is 1 or 2; R1 and R2 are each independently H or C1-C4 alkyl or together re- present -(CH2)p- where p is an integer of from 2 to 5; R3 is H or C1-C4 alkyl; wherein Z is a direct link, -CH2-, -CH2O- or -CH2S-; and R4 is a group of formulae (II), (III), (IV) or Het, where R5 and R6 are each independently H, C1-C4 alkyl, C1-C4 alkoxy, -(CH2)nOH, halo, trifluoromethyl, cyano, -(CH2)nNR7R8, -CO(C1-C4 alkyl), -OCO(C1-C4 alkyl), -CH(OH)(C1-C4 alkyl), -C(OH)(C1-C4 alkyl)2,-SO2NH2,-CH2)nCONR7R8 or -(CH2)nCOO(C1-C4 alkyl); R7 and R8 are each independently H or C1-C4 alkyl; n is 0,1 or 2; X and X1 are each independently O or CH2; q is 1, 2 or 3; and "Het" is pyridyl, pyrazinyl or thienyl.
Cross Peter Edward
Mackenzie Alexander Roderick
Pfizer Inc.
Smart & Biggar
LandOfFree
3-phenyglutarimide derivatives as muscarinic receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-phenyglutarimide derivatives as muscarinic receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-phenyglutarimide derivatives as muscarinic receptor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1906995